These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37477542)

  • 1. Design, in Silico Studies and Biological Evaluation of New Chiral Thiourea and 1,3-Thiazolidine-4,5-dione Derivatives.
    Evyapan S; Oruç-Emre EE; Sıcak Y; Karaküçük-İyidoğan A; Yılmaz GT; Öztürk M
    Chem Biodivers; 2023 Aug; 20(8):e202300626. PubMed ID: 37477542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antimicrobial, antioxidant, cytotoxic, antiurease and molecular docking studies of N-(3-trifluoromethyl)benzoyl-N'-aryl thiourea derivatives.
    Maalik A; Rahim H; Saleem M; Fatima N; Rauf A; Wadood A; Malik MI; Ahmed A; Rafique H; Zafar MN; Riaz M; Rasheed L; Mumtaz A
    Bioorg Chem; 2019 Jul; 88():102946. PubMed ID: 31054433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme Inhibitory, Antioxidant And Antibacterial Potentials Of Synthetic Symmetrical And Unsymmetrical Thioureas.
    Naz S; Zahoor M; Umar MN; Ali B; Ullah R; Shahat AA; Mahmood HM; Sahibzada MUK
    Drug Des Devel Ther; 2019; 13():3485-3495. PubMed ID: 31631973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
    Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
    Kadhim ZY; Alqaraghuli HGJ; Abd MT
    Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chandrasekhar M; Syam Prasad G; Venkataramaiah C; Umapriya K; Raju CN; Seshaiah K; Rajendra W
    J Recept Signal Transduct Res; 2020 Feb; 40(1):34-41. PubMed ID: 31910703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in silico studies and biological evaluation of 5-((
    Kumar H; Deep A; Marwaha RK
    BMC Chem; 2020 Dec; 14(1):25. PubMed ID: 32266332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, Molecular docking, and biological evaluation of novel 2,3-diaryl-1,3-thiazolidine-4-one derivatives as potential anti-inflammatory and cytotoxic agents.
    Mekhlef YO; AboulMagd AM; Gouda AM
    Bioorg Chem; 2023 Apr; 133():106411. PubMed ID: 36801792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsymmetrical thiourea derivatives: synthesis and evaluation as promising antioxidant and enzyme inhibitors.
    Bano B; Kanwal ; Hameed S; Lateef M; Wadood A; Shams S; Hussain S; Ain NU; Perveen S; Taha M; Khan KM
    Future Med Chem; 2024 Mar; 16(6):497-511. PubMed ID: 38372209
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies.
    Sıcak Y; Oruç-Emre EE; Öztürk M; Taşkın-Tok T; Karaküçük-Iyidoğan A
    Chirality; 2019 Aug; 31(8):603-615. PubMed ID: 31222828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies.
    Sava A; Buron F; Routier S; Panainte A; Bibire N; Profire L
    Biomed Pharmacother; 2021 Jul; 139():111678. PubMed ID: 33964802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazole based novel molecules as potential therapeutic agents: Synthesis, characterization, biological evaluation, in-silico ADME profiling and molecular docking studies.
    Şahin İ; Çeşme M; Özgeriş FB; Tümer F
    Chem Biol Interact; 2023 Jan; 370():110312. PubMed ID: 36535312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chalcones bearing nitrogen-containing heterocyclics as multi-targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies.
    Sıcak Y; Kekeçmuhammed H; Karaküçük-İyidoğan A; Taşkın-Tok T; Oruç-Emre EE; Öztürk M
    J Mol Recognit; 2023 Jul; 36(7):e3020. PubMed ID: 37092742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
    Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cyclic thiourea derivatives of aminoalcohols at the presence of AlCl
    Sujayev A; Taslimi P; Garibov E; Karaman M; Mahdi Zangeneh M
    Bioorg Chem; 2020 Nov; 104():104216. PubMed ID: 32911191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileishmanial Thioureas: Synthesis, Biological Activity and in Silico Evaluations of New Promising Derivatives.
    Viana GM; Soares DC; Santana MV; do Amaral LH; Meireles PW; Nunes RP; da Silva LCRP; Aguiar LCS; Rodrigues CR; de Sousa VP; Castro HC; Abreu PA; Sathler PC; Saraiva EM; Cabral LM
    Chem Pharm Bull (Tokyo); 2017; 65(10):911-919. PubMed ID: 28966275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
    Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
    Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents.
    Fettach S; Thari FZ; Hafidi Z; Karrouchi K; Bouathmany K; Cherrah Y; El Achouri M; Benbacer L; El Mzibri M; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2023 Feb; 41(3):1072-1084. PubMed ID: 34957934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies.
    Zaib S; Saeed A; Stolte K; Flörke U; Shahid M; Iqbal J
    Eur J Med Chem; 2014 May; 78():140-50. PubMed ID: 24681391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.